Showing results (1-10 of 105) with videos related to
Sort By:
Pageof 11
Der Urologe. Ausg. A|February 2, 2020
[Risk-adapted therapy for metastatic renal cell carcinoma]M-O Grimm, K Leucht, S Foller, et al.Der Urologe. Ausg. A|October 28, 2021
[Bacillus Calmette-Guérin (BCG) and alternatives : Drug treatment of high-risk non-muscle invasive bladder cancer]K Leucht, S Foller, Marc-Oliver GrimmDer Urologe. Ausg. A|October 19, 2018
[Tumor assessment in immune checkpoint inhibitor therapy : Tumor response, progression and pseudoprogression]S Foller, H Oppel-Heuchel, M-O GrimmDer Urologe. Ausg. A|April 18, 2018
[Treatment with PD-1/PD-L1 and CTLA-4 immune checkpoint inhibitors : Immune-mediated side effects]M-O Grimm, H Oppel-Heuchel, S FollerDer Urologe. Ausg. A|March 2, 2017
[Adverse events of immune checkpoint inhibitors]S Foller, H Oppel-Heuchel, I Fetter, et al.Der Urologe. Ausg. A|January 11, 2019
[Follow-up of renal cell carcinoma in a nonmetastatic stage]B Szabados, S Foller, G B Schulz, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 18, 2025
Open versus robotic-assisted partial nephrectomy in patients with intermediate/high-complexity kidney tumours: final results of the randomised, controlled, open-label, multicentre trial OpeRaM-O Grimm, J Bedke, J Nyarangi-Dix, et al.Der Urologe. Ausg. A|October 24, 2018
[Risk-adapted (immuno)therapy for renal cell carcinoma]V GrünwaldDer Internist|August 21, 2014
[Pharmacotherapy of solid tumors. New hopes and frustrations]V Grünwald, M RickmannPageof 11